The Andrology SIG has been an active participant at the annual CFAS meetings since its inception in 2008. The aim of the Andrology SIG is to promote the field of Andrology and disseminate the latest advances in this area to Canadian clinicians, scientists and allied professionals working in reproductive biology. The Andrology SIG also acts as a resource for Canadian health care professionals and promotes the exchange of ideas and information in this field. At the last three annual CFAS meetings, the Andrology and ART laboratory SIGs have held joint sessions at the ART Professionals day in order to enhance the educational experience and increase the profile of these two SIGs. Once again, the Andrology and ART laboratory SIGs will hold a joint session at the ART Professionals day at the upcoming CFAS meeting in Toronto (September 2016).
Membership Benefits Joining the Andrology SIG gives you the opportunity to:
- Influence the direction of your profession in Canada
- Network with other Andrologists from across Canada
- Remain updated on the latest advances in Andrology
How to Join You need to be a member of the CFAS in good standing, and be interested or involved in the delivery or direction of Andrology services. If you would like more information, please contact:
Dr. Sarah Kimmins
Chair Andrology SIG 2019
Sarah Kimmins, Chair, BSc, MSc, PhD
Dr. Kimmins received her Ph.D. from Dalhousie University in 2003 and completed her post-doctoral training at the Institut de Génétique etBiologie Moleculaire et Cellulaire in Strasbourg, France in 2005. She was appointed to the Department of Animal Science in the Faculty of Agricultural and Environmental Sciences in September of 2005 and is a tenured Associate Professor. She is an associate member of the Department of Pharmacology and Therapeutics, Faculty of Medicine at McGill. She holds a Tier II Canada Research Chair in Epigenetics, Reproduction and Development and was the Associate Director for the McGill Center for the Study of Reproduction (2014-2017). In 2019 she received the Canadian Fertility and Andrology Society exchange speaker award with the Society for the Study of Reproduction. In 2014 she received the Young Andrologist Award from the American Society of Andrology, and in 2016 the Society for the Study of Reproduction Young Investigator award. She is a frequent invited speaker with over 80 national and international presentations including the American Society for Andrology, Keystone Symposia, the Society for the Study of Reproduction and at the Gordon Research Conference series. She has served as a grant peer reviewer for CIHR, the National Institutes of Health (USA) and the Medical Research Council (United Kingdom) and is extensively involved in several international societies at the council and committee levels. She is an Associate editor for Biology of Reproduction and Environmental Health Perspectives. She was an elected council member for the Society for the Study of Reproduction (2016-2019).
Her research team is focussed on understanding the molecular mechanisms underpinning epigenetic inheritance. Particular interest is given to paternal health and how environmental exposures (diet, BMI, toxicants) alter fertility, clinical outcomes, the sperm epigenome, development and health of offspring. Based on mechanistic studies in mice and translational studies in men they are developing new interventions and technologies to optimize fertility and to diagnose and treat infertility in men. In the long-term they aim to improve the pre-conception health of men and children.
Sergey I. Moskovtsev MD, PhD - Vice-Chair
Sergey I. Moskovtsev MD, PhD is the Director of Andrology at the CReATe Fertility Clinic in Toronto, Canada. He was trained as a research physician in his native Russia followed by postdoctoral fellowship and at the Division of Andrology, Department of Urology, University of Utah and a three-year research fellowship at the Department of Pathology & Laboratory Medicine at Mount Sinai Hospital in Toronto. He received an appointment in 2010 as Assistant Professor with the Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Toronto. He has recently served for three years as Chairman of the Andrology Special Interest Group and Advisory Council of Canadian Fertility and Andrology Society (CFAS).
Sergey’s research interest is idiopathic male infertility; sperm DNA damage, telomere length and epigenetics of male infertility. He is involved in intensive research collaboration with several medical institutions across North America. His research has resulted in a number of peer reviewed papers, presentations at national and international meetings and several grants including CIHR.
Armand Zini, MD, FRCS(C) - Scientific Subcommittee Chair
Dr. Armand Zini is Professor of Urology at McGill University and Head of the Division of Urology at St. Mary’s Hospital in Montreal. Dr. Zini is also the Director of the Andrology Fellowship program at McGill University.
Dr. Zini received his Medical degree and completed his urologic training at McGill University in Montreal. He then completed a fellowship in Male Infertility at the New York Hospital-Cornell Medical Centre and The Population Council in New York.
Dr. Zini’s main expertise is in the area of male infertility. His clinical research interests include varicoceles, sperm retrieval techniques and the role of semen oxidants and antioxidants in male infertility. He has focused his basic research activity on the study of human sperm DNA damage and the impact of this damage on male fertility potential.